AU3387593A - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds

Info

Publication number
AU3387593A
AU3387593A AU33875/93A AU3387593A AU3387593A AU 3387593 A AU3387593 A AU 3387593A AU 33875/93 A AU33875/93 A AU 33875/93A AU 3387593 A AU3387593 A AU 3387593A AU 3387593 A AU3387593 A AU 3387593A
Authority
AU
Australia
Prior art keywords
relating
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33875/93A
Inventor
Paul Leroy Anderson
William Joseph Houlihan
Prasad Kotesware Kapa
Andrew Kucerovy
Paul Gerard Mattner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU3387593A publication Critical patent/AU3387593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU33875/93A 1992-03-03 1993-03-01 Improvements in or relating to organic compounds Abandoned AU3387593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84512392A 1992-03-03 1992-03-03
US845123 1992-03-03

Publications (1)

Publication Number Publication Date
AU3387593A true AU3387593A (en) 1993-09-09

Family

ID=25294463

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33875/93A Abandoned AU3387593A (en) 1992-03-03 1993-03-01 Improvements in or relating to organic compounds

Country Status (14)

Country Link
EP (1) EP0564397A1 (en)
JP (1) JPH0649076A (en)
KR (1) KR930019642A (en)
CN (1) CN1076445A (en)
AU (1) AU3387593A (en)
CA (1) CA2090635A1 (en)
CZ (1) CZ30293A3 (en)
FI (1) FI930922A (en)
HU (1) HUT63629A (en)
IL (1) IL104892A0 (en)
NO (1) NO930739L (en)
NZ (1) NZ247032A (en)
TW (1) TW227563B (en)
ZA (1) ZA931516B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1655289A1 (en) * 2004-11-04 2006-05-10 Embl Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives
AU2012266378B2 (en) * 2011-06-10 2017-03-02 Chiesi Farmaceutici S.P.A. Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CN104119231A (en) * 2013-04-27 2014-10-29 重庆华邦制药有限公司 Preparation method and intermediate of benzhydrylamine compound
US9834525B2 (en) 2014-02-04 2017-12-05 University Of Tennessee Research Foundation Inhibitors of paxillin function and related compositions and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242863A (en) * 1968-05-10 1971-08-18 Pharmacia As 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
DE3734909A1 (en) * 1987-10-15 1989-04-27 Boehringer Ingelheim Kg USE OF OXOCHINAZOLINE DERIVATIVES IN THE TREATMENT OF HYPERLIPIDAEMIA

Also Published As

Publication number Publication date
CA2090635A1 (en) 1993-09-04
HU9300556D0 (en) 1993-05-28
CN1076445A (en) 1993-09-22
NO930739D0 (en) 1993-03-01
JPH0649076A (en) 1994-02-22
KR930019642A (en) 1993-10-18
FI930922A (en) 1993-09-04
CZ30293A3 (en) 1993-12-15
HUT63629A (en) 1993-09-28
ZA931516B (en) 1994-09-03
FI930922A0 (en) 1993-03-02
EP0564397A1 (en) 1993-10-06
TW227563B (en) 1994-08-01
IL104892A0 (en) 1993-07-08
NZ247032A (en) 1994-11-25
NO930739L (en) 1993-09-06

Similar Documents

Publication Publication Date Title
AU3523793A (en) Improvements in or relating to organic compounds
AU7167394A (en) Improvements in or relating to organic compounds
AU1852792A (en) Improvements in or relating to organic compounds
AU1631792A (en) Improvements in or relating to organic compounds
AU1294092A (en) Improvements in or relating to organic compounds
AU6471494A (en) Improvements in or relating to organic compounds
AU8464791A (en) Improvements in or relating to organic compounds
AU7761094A (en) Improvements in or relating to organic compounds
AU682674B2 (en) Improvements in or relating to organic compounds
AU5211293A (en) Improvements in or relating to organic compounds
AU2630292A (en) Improvements in or relating to organic compounds
AU3848593A (en) Improvements in or relating to organic compounds
AU3110493A (en) Improvements in or relating to organic compounds
AU4219593A (en) Improvements in or relating to organic compounds
AU2630392A (en) Improvements in or relating to organic compounds
AU7833191A (en) Improvements in or relating to organic compounds
AU7005291A (en) Improvements in or relating to organic compounds
AU682483B2 (en) Improvements in or relating to organic compounds
AU2051492A (en) Improvements in or relating to organic compounds
AU8472391A (en) Improvements in or relating to organic compounds
AU5782494A (en) Improvements in or relating to organic compounds
GB9201011D0 (en) Improvements in or relating to organic compounds
AU1065392A (en) Improvements in or relating to organic compounds
AU3387593A (en) Improvements in or relating to organic compounds
AU654717B2 (en) Improvements in or relating to organic compounds